Alnylam Pharmaceuticals
ALNY
#638
Rank
HK$246.09 B
Marketcap
HK$1,897
Share price
-0.59%
Change (1 day)
30.45%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: HK$246.09 Billion

As of December 2024 Alnylam Pharmaceuticals has a market cap of HK$246.09 Billion. This makes Alnylam Pharmaceuticals the world's 638th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$246.09 B31.18%
2023HK$187.60 B-17.88%
2022HK$228.44 B44.45%
2021HK$158.14 B35.1%
2020HK$117.05 B16.33%
2019HK$100.62 B74.2%
2018HK$57.76 B-41.32%
2017HK$98.44 B295.12%
2016HK$24.91 B-59.87%
2015HK$62.08 B6.89%
2014HK$58.08 B82.76%
2013HK$31.78 B328.03%
2012HK$7.42 B174.54%
2011HK$2.70 B-16.76%
2010HK$3.24 B-43.16%
2009HK$5.71 B-27.78%
2008HK$7.91 B-14.39%
2007HK$9.24 B49.91%
2006HK$6.16 B208.73%
2005HK$1.99 B78.44%
2004HK$1.11 B

End of Day market cap according to different sources

On Dec 16th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

HK$244.64 Billion
by Yahoo Finance info icon info icon
HK$244.64 Billion
by CompaniesMarketCap info icon info icon
HK$244.64 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$21.63 B-91.21%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$624.72 B 153.85%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$94.14 B-61.74%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$8.36 B-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.83 B-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.519 T 517.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$910.07 B 269.80%๐Ÿ‡ซ๐Ÿ‡ท France
HK$145.42 B-40.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel